From: Molecular and clinical analyses of 84 patients with tuberous sclerosis complex
 | N | MM | NM | FM | SM | Total |
---|---|---|---|---|---|---|
TSC1mutaions | Â | Â | Â | Â | Â | Â |
Familial | 2 | 0 | 1 | 1 | 0 | 2 (3 %) |
Sporadic | 7 | 0 | 4 | 3 | 0 | 7 (11 %) |
Total | 9 | 0 (0 %) | 5 (8 %) | 4 (6 %) | 0 (0 %) | 9 (14 %) |
TSC2 mutations | Â | Â | Â | Â | Â | Â |
Familial | 8 | 4 | 0 | 4 | 0 | 8 (13 %) |
Sporadic | 47 | 8 | 15 | 17 | 7 | 47 (73 %) |
Total | 55 | 12 (19 %) | 15 (23 %) | 21 (33 %) | 7 (11 %) | 55 (86 %) |